Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange Program

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Scandiatransplant Exchange Program (STEP) : Development and Results From an International Kidney Exchange Program. / Duus Weinreich, Ilse; Andersson, Tommy; Birna Andrésdóttir, Margrét; Bengtsson, Mats; Biglarnia, Alireza; Bistrup, Claus; Boulland, Line; Bruunsgaard, Helle; Helanterä, Ilkka; Kölvald, Kulli; Lauronen, Jouni; Lindahl, Jørn Petter; Skov, Karin; Schwarz Sørensen, Søren; Wennberg, Lars; Lindner, Per.

In: Transplantation Direct, Vol. 9, No. 11, E1549, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Duus Weinreich, I, Andersson, T, Birna Andrésdóttir, M, Bengtsson, M, Biglarnia, A, Bistrup, C, Boulland, L, Bruunsgaard, H, Helanterä, I, Kölvald, K, Lauronen, J, Lindahl, JP, Skov, K, Schwarz Sørensen, S, Wennberg, L & Lindner, P 2023, 'Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange Program', Transplantation Direct, vol. 9, no. 11, E1549. https://doi.org/10.1097/TXD.0000000000001549

APA

Duus Weinreich, I., Andersson, T., Birna Andrésdóttir, M., Bengtsson, M., Biglarnia, A., Bistrup, C., Boulland, L., Bruunsgaard, H., Helanterä, I., Kölvald, K., Lauronen, J., Lindahl, J. P., Skov, K., Schwarz Sørensen, S., Wennberg, L., & Lindner, P. (2023). Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange Program. Transplantation Direct, 9(11), [E1549]. https://doi.org/10.1097/TXD.0000000000001549

Vancouver

Duus Weinreich I, Andersson T, Birna Andrésdóttir M, Bengtsson M, Biglarnia A, Bistrup C et al. Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange Program. Transplantation Direct. 2023;9(11). E1549. https://doi.org/10.1097/TXD.0000000000001549

Author

Duus Weinreich, Ilse ; Andersson, Tommy ; Birna Andrésdóttir, Margrét ; Bengtsson, Mats ; Biglarnia, Alireza ; Bistrup, Claus ; Boulland, Line ; Bruunsgaard, Helle ; Helanterä, Ilkka ; Kölvald, Kulli ; Lauronen, Jouni ; Lindahl, Jørn Petter ; Skov, Karin ; Schwarz Sørensen, Søren ; Wennberg, Lars ; Lindner, Per. / Scandiatransplant Exchange Program (STEP) : Development and Results From an International Kidney Exchange Program. In: Transplantation Direct. 2023 ; Vol. 9, No. 11.

Bibtex

@article{442671f758534e1a8104c64588c549fe,
title = "Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange Program",
abstract = "Background. Kidney transplant candidates may be incompatible with their intended living donors because of the presence of antibodies against HLA and/or ABO. To increase the possibility of finding an acceptable kidney donor for these patients, the Scandiatransplant Exchange Program (STEP) program within Scandiatransplant was launched in 2019. Methods. This is a retrospective review of our experiences from the first 4 y of the STEP program, including details about the match runs, performed transplantations, and recipient outcomes within the program. Results. During 2019-2022, 11 match runs and 4 reruns were performed. In total, 114 pairs and 6 anonymous donors participated in these match runs. Fifty-one pairs (45%) participated in 1 match run, 31 pairs (27%) participated in 2 match runs, and 32 pairs (29%) participated in ≥3 match runs. Seventy-two individuals (63%) participated because of HLA incompatibility, 19 (17%) because of ABO incompatibility, and 7 (6%) because of both HLA and ABO incompatibility. Forty percent of the patients enrolled in the program underwent transplantation. In total, 49 transplantations have so far been performed within the program, and 46 (94%) of the recipients had a functioning kidney graft at follow-up in February 2023. Conclusions. The STEP program offers sensitized patients an enlarged pool of living donors and a chance of a compatible international living donor, resulting in an increased number of total transplantations. Currently, STEP is one of the largest transnational kidney exchange programs and has improved the situation for patients waiting for kidney transplantation in Scandiatransplant.",
author = "{Duus Weinreich}, Ilse and Tommy Andersson and {Birna Andr{\'e}sd{\'o}ttir}, Margr{\'e}t and Mats Bengtsson and Alireza Biglarnia and Claus Bistrup and Line Boulland and Helle Bruunsgaard and Ilkka Helanter{\"a} and Kulli K{\"o}lvald and Jouni Lauronen and Lindahl, {J{\o}rn Petter} and Karin Skov and {Schwarz S{\o}rensen}, S{\o}ren and Lars Wennberg and Per Lindner",
note = "Publisher Copyright: Copyright {\textcopyright} 2023 The Authors. Published by Wolters Kluwer Health, Inc.",
year = "2023",
doi = "10.1097/TXD.0000000000001549",
language = "English",
volume = "9",
journal = "Transplantation Direct",
issn = "2373-8731",
publisher = "Lippincott Williams & Wilkins",
number = "11",

}

RIS

TY - JOUR

T1 - Scandiatransplant Exchange Program (STEP)

T2 - Development and Results From an International Kidney Exchange Program

AU - Duus Weinreich, Ilse

AU - Andersson, Tommy

AU - Birna Andrésdóttir, Margrét

AU - Bengtsson, Mats

AU - Biglarnia, Alireza

AU - Bistrup, Claus

AU - Boulland, Line

AU - Bruunsgaard, Helle

AU - Helanterä, Ilkka

AU - Kölvald, Kulli

AU - Lauronen, Jouni

AU - Lindahl, Jørn Petter

AU - Skov, Karin

AU - Schwarz Sørensen, Søren

AU - Wennberg, Lars

AU - Lindner, Per

N1 - Publisher Copyright: Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc.

PY - 2023

Y1 - 2023

N2 - Background. Kidney transplant candidates may be incompatible with their intended living donors because of the presence of antibodies against HLA and/or ABO. To increase the possibility of finding an acceptable kidney donor for these patients, the Scandiatransplant Exchange Program (STEP) program within Scandiatransplant was launched in 2019. Methods. This is a retrospective review of our experiences from the first 4 y of the STEP program, including details about the match runs, performed transplantations, and recipient outcomes within the program. Results. During 2019-2022, 11 match runs and 4 reruns were performed. In total, 114 pairs and 6 anonymous donors participated in these match runs. Fifty-one pairs (45%) participated in 1 match run, 31 pairs (27%) participated in 2 match runs, and 32 pairs (29%) participated in ≥3 match runs. Seventy-two individuals (63%) participated because of HLA incompatibility, 19 (17%) because of ABO incompatibility, and 7 (6%) because of both HLA and ABO incompatibility. Forty percent of the patients enrolled in the program underwent transplantation. In total, 49 transplantations have so far been performed within the program, and 46 (94%) of the recipients had a functioning kidney graft at follow-up in February 2023. Conclusions. The STEP program offers sensitized patients an enlarged pool of living donors and a chance of a compatible international living donor, resulting in an increased number of total transplantations. Currently, STEP is one of the largest transnational kidney exchange programs and has improved the situation for patients waiting for kidney transplantation in Scandiatransplant.

AB - Background. Kidney transplant candidates may be incompatible with their intended living donors because of the presence of antibodies against HLA and/or ABO. To increase the possibility of finding an acceptable kidney donor for these patients, the Scandiatransplant Exchange Program (STEP) program within Scandiatransplant was launched in 2019. Methods. This is a retrospective review of our experiences from the first 4 y of the STEP program, including details about the match runs, performed transplantations, and recipient outcomes within the program. Results. During 2019-2022, 11 match runs and 4 reruns were performed. In total, 114 pairs and 6 anonymous donors participated in these match runs. Fifty-one pairs (45%) participated in 1 match run, 31 pairs (27%) participated in 2 match runs, and 32 pairs (29%) participated in ≥3 match runs. Seventy-two individuals (63%) participated because of HLA incompatibility, 19 (17%) because of ABO incompatibility, and 7 (6%) because of both HLA and ABO incompatibility. Forty percent of the patients enrolled in the program underwent transplantation. In total, 49 transplantations have so far been performed within the program, and 46 (94%) of the recipients had a functioning kidney graft at follow-up in February 2023. Conclusions. The STEP program offers sensitized patients an enlarged pool of living donors and a chance of a compatible international living donor, resulting in an increased number of total transplantations. Currently, STEP is one of the largest transnational kidney exchange programs and has improved the situation for patients waiting for kidney transplantation in Scandiatransplant.

U2 - 10.1097/TXD.0000000000001549

DO - 10.1097/TXD.0000000000001549

M3 - Journal article

C2 - 37854025

AN - SCOPUS:85175238332

VL - 9

JO - Transplantation Direct

JF - Transplantation Direct

SN - 2373-8731

IS - 11

M1 - E1549

ER -

ID: 396106432